Background Globally there are several operational definitions for sarcopenia, complicating
clinical and research applications. Objective The objective of the Australian and New …

Background Sarcopenia is an age‐associated skeletal muscle condition characterized by
low muscle mass, strength, and physical performance. There is no international consensus …

Objectives Multinational prevalence data on sarcopenia among generally healthy older
adults is limited. The aim of the study was to assess prevalence of sarcopenia in the DO …

Introduction: sarcopenia is associated with adverse health outcomes. The aim of this study
was to describe the prevalence of sarcopenia in community-dwelling older people in the UK …

Aim To develop cut‐off points of muscle mass, gait speed and handgrip strength; and to
examine the prevalence of sarcopenia, and the relationship between sarcopenia stages and …

Abstract Introduction recently, the European Working Group on Sarcopenia in Older People
(EWGSOP) established a new operational definition and cut-off points for sarcopenia. The …

Introduction The critical sociodemographic, lifestyle and diseases factors influencing
sarcopenia, defined by the current European Working Group on Sarcopenia 2 (EWGSOP2) …

Sarcopenia, a geriatric syndrome characterized by progressive skeletal muscle mass and
function decline, poses a significant health risk among the elderly, contributing to frailty, falls …

Objectives Sarcopenia is a debilitating condition affecting millions of individuals worldwide
and is defined with different criteria. The objective of this study was to determine the …

Importance Sarcopenia, the age-related loss of muscle mass and strength/function, is an
important clinical condition. However, no international consensus on the definition exists …